malignancy
Conditions
Interventions
Chemotherapy cohort:No
Without chemotherapy chort:No
Sponsors
Obstetrics & Gynecology Hospital of Fudan University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Patients who became pregnant between January 1, 2000 and December 30, 2020 and were diagnosed with primary invasive and borderline ovarian cancer before delivery were included. The diagnosis of all patients should be based on pathology; 2) Participants voluntarily participated in the study and provided written or oral informed consent (via telephone recording).
Exclusion criteria
Exclusion criteria: 1) Patients with preinvasive disease or post-partum diagnosis; 2) Patients with primary invasive cancer or borderline ovarian cancer diagnosed after delivery; 3) Patients who received high-dose scatter radiation therapy for the pelvis and brain before delivery; 4) Patients who were found to be younger than 15 years old and older than 45 years at the time of pregnancy; 5) Patients with high risk factors for pregnancy other than malignant tumors such as multiple miscarriages; 6) Patients who cannot or refuse to sign informed consent; 7) Patients who voluntarily ask to withdraw from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse pregnancy outcome; | — |
Countries
China
Contacts
Public ContactTang Jing
Obstetrics & Gynecology Hospital of Fudan University
Outcome results
None listed